Browse diseases

… or serious epidemic caused by a known or yet unknown pathogen (Disease X) is a global health priority. Controlled human infection studie…

…l research while allowing for an expansive investigation of the COVID-19 disease course.…

…tcomes. Continuing to train when unwell with infections such as SARS-CoV-2, adenovirus, enterovirus and influenza risks increasing viral l…

…ers (HCWs) played a critical role in the global response to the COVID-19 pandemic, providing essential frontline care while putting them…

…erved prepandemic with small variance in mean rates. Due to the COVID-19 pandemic, border closures and then SARS-CoV-2 arrival, there wa…

…Introduction Residual COVID-19 sequelae create a public health concern as they add to the alre…

…stimate the pooled prevalence of HA-COVID-19 among hospitalised COVID-19 patients globally and investigate differences by country, type …

… (SSc) and idiopathic inflammatory myopathies (IIM) is known as Scleromyositis. Most cases of overlap are SSc-polymyositis/dermatomyositis. An…

…talization, 51.4% (74/144) developed ARDS and 18.8% (27/144) of COVID-19 patients died. Fatigue (57%) at T1 and dyspnea (14.2%) at T2 we…

…ls, this strategy has been already applied successfully against SARS-CoV-2 and tumors (HPV-associated and breast cancer), supporting the r…

…e 1Humoral and cellular immune responses in patients with acute SARS-CoV-2 infection treated early with monoclonal antibodies, stratified according …

…ination strategies remains critical in mitigating the threat of COVID-19.…